Scott Thies
About Scott Thies
Scott Thies is an Executive Director at Sana Biotechnology, Inc., where he has worked since 2019. He has a background in biology and chemistry, holding a B.S. from the University of Miami and a Ph.D. in Physiology from Duke University, with previous roles at Geron and Fate Therapeutics.
Current Role at Sana Biotechnology
Scott Thies serves as the Executive Director at Sana Biotechnology, Inc., a position he has held since 2019. His role involves overseeing various initiatives within the company, which focuses on developing cell and gene therapies. Located in the Greater Seattle Area, Sana Biotechnology aims to create transformative therapies for patients with serious diseases.
Previous Experience at Geron
Scott Thies worked at Geron from 2001 to 2008 as the Director of Cell Technologies. During his seven years at Geron, he contributed to advancements in cell technology, which played a significant role in the company's research and development efforts in regenerative medicine.
Experience at Fate Therapeutics
From 2008 to 2013, Scott Thies held the position of Senior Director of Stem Cell Biology at Fate Therapeutics. His five-year tenure at the company involved leading research efforts focused on stem cell biology, contributing to the development of innovative therapies in the field.
Education and Academic Background
Scott Thies earned a Bachelor of Science degree in Biology and Chemistry from the University of Miami, where he studied from 1975 to 1979. He later pursued a Ph.D. in Physiology at Duke University, completing his studies from 1979 to 1984. His educational background provides a strong foundation for his career in biotechnology and cell therapy.